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In all mammalian species so far examined, Langer hans 
cells or their precursors are the only epidermal cells 
expressing Ia antigens or their equivalents. In man, xe-
noantisera raised in rabbits against purified B lympho-
cyte cell membrane antigens were utilized to stain the 
Langerhans cells, by either fluorescence or immunofer-
ritin methods. A high proportion of the indeterminate 
cells in the epidermis also expressed HLA-DR antigens, 
and a relationship to Langerhans cells is suggested. 
Confirmation of these results was obtained in mouse. 
Alloantisera raised against I-A and 1-EC subregion prod-
ucts again stained only Langerhans cells. Fluorescence, 
immunoperoxidase, and immunoferritin methods were 
used, and confirmation of the specificity of the reaction 
was achieved at the electron microscope level. 
Langerhans cells were shown, by ATPase staining, to 
be absent from the epithelium of the central cornea, but 
were present in the limbus. Population of the entire 
corneal epithelium surface was induced by application 
of irritants or contact sensitizing agents such as dini-
trochlorobenzene. Grafting of corneas either deficient or 
populated with Langerhans cells, to skin beds, may an-
swer the question of the influence of such cells on allo-
graft rejection. 
The demonstration in 1977, by 2 independent groups, that 
Langerhans cells (LCs) express Ia-like antigens* [1,2] has pro-
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Abbreviations: 
E; EA; a nd EAC: ovine erythrocyte; ovine erythrocyte with anti-
body; and ovine erythrocyte with antibody and complement 
GVH reaction: graft-versus-hos t r-eaction 
HLA-DR a ntigen: HLA-D -region-related antigen 
IDC: inte rdigitating reticulum ceH 
IEM: immunoelectron microscopy 
Ia antigen : immune-response-associated antigen 
lr region: immune-response region 
LC: Langerhans cell 
LD a ntigen: leukocyte-defined antigen 
MHC: major histocompatibility complex 
MLC: mixed lymphocyte cu lture 
MPS: mononuclear phagocyte system 
MSL reaction: mixed skin-leukocyte reaction 
SD antigen: serologically defined antigen 
Slg: s urface immunoglobulin 
Sk antigen: skin-specific antigen 
• The terms "Ia-like antigen," "B cell alloantigen," and "HLA-DR 
antigen" are currently in use to describe, for different purposes, the 
same or closely related entities. 
"Ia-like a n tigen" implies a t issue distribution and structural proper-
t ies similar to those of murine Ia (immune-t·esponse-associated) antigen. 
"B cell alloantigen" implies restr-iction of the antigenic specificity to B 
ceUs, but not to T cells. "HLA-DR (D-locus-related) antigen" refers to 
alloantigenic determinants recognized by antiserum analyses at the 
VIIth Histocompatibility Testing Workshop in Oxford, 1977. 
There is usually a strong correlation between HLA-DR antigens and 
the products of the HLA-D locus, as defined by the mixed lymphocyte 
reaction. 
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vided a fresh impetus to investigations of the origins, nature 
and function of these cells. ' 
HISTORY OF SUGGESTIONS ABOUT IMMUNE 
FUNCTIONS OF LANGERHANS CELLS 
Research into the origin and function of the LC has gone 
through several distinct phases since its original description itl 
1868 [3). In particular, many publications in the 1960s followect 
the discovery of the characteristic granules by Birbeck, Breath-
nach, and Ever all [ 4). This discovery was followed by a decline 
in interest, until development of appropriate immunologic tech-
niques permitted reinvestigation of earlier suggestions concern-
ing the immune functions of these cells. Figure 1 illustrates the 
fluctuation of interest in LCs by plotting the number of publi-
cations per year. 
LCs may now be considered members of the mononuclear 
phagocyte system (MPS), and they have been christened reti-
culoepithelial cells [5]. They are, therefore, epidermal macr0 _ 
ph~g~s. The fact that they ·have relatively poor phagocytotic 
activity [6] does not interfere with their placement within this 
system. Earlier reviews (7-9] detailed studies related to 
"neural" and "melanocytic" theories; therefore, attention herein 
will only be directed to studies pertinent to immune functions 
for LCs. 
Lar:g~~hans _cells aYe independent populations of cells in 
keratmlZmg epithelia, unrelated to melanocytes, keratinocytes 
or Merkel cells. The epidermis is, therefore, a quaternary struc: 
ture. The experiments of Breathnach and colleagues [10] and 
t~e observation of extraepidermal locations of LCs in such 
di~e~se sta~es as histiocytosis X [11,12] indicated that LCs 
ong:nated m the mesoderm. Once their existence outside the 
confmes of keratinizing epithelia had been reported, they were 
rapidly detected in normal and pathologic lymphoid tissue, i.e. 
lymph nodes, spleen, and thymus [13-15]. ' 
The ~artiest mention of a possible relationship of LCs to cells 
o~ the Immune system was made only a few years after their 
d1scovery. Eberth [16] (quoted in Ranvier [17]) thought the 
LC~ were migratory lymphoid cells and not of neural origin. 
This proposal was adopted by Arnstein [18]. Subsequently 
other workers speculated about the relationships of LCs t~ 
lymphocytes and macrophages and about the role of LCs in 
antigen processing [12,15,19-21]. It was a review by Prunieras 
[20] that stimulated many workers to consider ways of investi-
gating the involvement of LCs in antigen binding and process-
ing. 
As long ago as 1949, Andrew and Andrew [22] called attention 
to lymphocytes and "clear cells" in the epidermis; despite these 
investigators' unfortunate attempts to relate such cells to ker-
atinocyte development, their observation now appears to be 
relevant to the roles played by LCs in the epidermis. Even 
Andrew's 2nd paper in 1969 (23] failed to receive the attention 
it deserved. And yet, these studies may have spurred later 
interest in "passenger lymphocytes" in both skin and other 
organs [24,25]. 
Recent resurgence of interest in the LC has probably been 
due to the careful studies by Silberberg-Sinakin, Baer, and 
Thorbecke on contact allergic reactions in skin [26]. These 
investigators reported LCs in dermal vessels of passively sen-
sitized guinea pigs [27); similar observations were also made by 
Breathnach, Porro, and Martin in pityriasis (tinea) versicolor 
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FIG 1. Graph of publications related to Langerhans cells (1961-
1978). 
[28] and by Breathnach [29] in striae distensae rubrae. 
Although current investigations may employ other markers 
for LCs that appear more frui tful than electron microscopy, i. e., 
Fe or C3 receptors and smface Ia (immune-response-associated) 
antigens, ul trastructural analysis will no doubt continue to be 
essential for ultimate proof of identity. Whatever characteristics 
are used to identify the LCs in the epidermis, such cells must 
contain a Birbeck granule. This area is troublesome, especially 
with respect to studies on the putative precmsor cells. If t he 
granules prove to be differentiation products, i.e., if the LCs in 
the epidermis are "end-stage" cells, a number of umelated cells 
might be called Langerhans cells. 
CONTACT ALLERGIC HYPERSENSITIVITY 
The interaction between various low-molecular-weight com-
pounds and skin has been studied since the pioneering obser-
vations of Landsteiner and Jacobs (30]. Although the exact 
nature of tissue "carrier" protein has not been determined, 
many experiments indicate that epidermal cell preparations are 
the most potent source (31). 
Contact sensitization via other epithelia has been reported to 
be less effective. However, when there is continued exposure of 
epithelia to hapten, sensitization can occm via oral, vaginal, 
and even colonic epithelium (32,33]. Langer hans cells are known 
to be present in all of these stratified epithelia, but in the case 
of colonic epithelium sensitization could occur via LCs in the 
rectum. 
Observations related to tolerance induction after oral inges-
tion or instillation by stomach tube suggest that different 
immune processing mechanisms ar e activated when LCs in 
stratified squamous epithelium are avoided (34]. 
In a series of studies Silberberg-Sinakin, Baer, and Thorbecke 
(26] demonstrated in guinea pigs and in mar: that after cuta-
neous application LCs bind and transport varwus haptens and 
antigens to local draining lymph nodes. These phenomena occur 
in both actively and passively sensitized animals. Langerhans 
cells may or may not be involved in the afferent arm of the 
immune response, but the observed apposition of mononuclear 
cells (lymphocytes) to LCs and subsequent damage to the cells 
and surrounding keratinocytes have been interpreted as an 
involvement as target cells in the efferent arm (35]. The conclu -
sions that have been drawn from these studies are listed below. 
First, LCs are capable of binding a variety of com~ on cont~ct 
allergens. Shelley and Juhlin [36] haveconfu·med th1s capacity; 
the earlier staining methods used to show these cells may have 
succeeded because of this proper ty. 
Second LCs are capable of movement to local draining lymph 
nodes. Although LCs are rarely captmed in transit either in the 
dermis or in lymphatic vessels, Kelly and associates [37,38] 
have substantiated Silberberg-Sinakin's observation. Further-
more, the presence ofLCs in both normal and pathologic lymph 
nodes is now explicable [13-15]. Since these cells have seldom 
been seen in the dermis and lymph vessels, perhaps LCs travel 
rapidly and at defined times after challenge with contactants. 
Third, LCs appear to act as targets for lymph?cytes i~ the 
challenge reaction. Presumably, the lymphocytes m the ep1der-
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mis either are collecting information (peripheral sensitization 
[39]) or are committed against the hapten-protein complex. 
It is assumed that LCs carrying the haptens have the ability 
to present them in the lymph nodes in a manner that induces 
the production of clones of specifically sensitized T cells. Recent 
studies (described later) support this suggestion. Specifically 
committed lymphocytes in their migration through various 
tissue spaces- they have ·a peculiar affinity for the epidermis 
[ 40]-recognize the hapten in association with a particular 
surface antigenic configuration on LCs. (The importance of T 
lymphocyte homing or ecotoxis will be discussed more fully 
with the "passenger cell concept." ) 
Langerhans cells have been implicated as the target cells 
responsible for the pathologic changes seen in the epidermis in 
contact challenge reactions, and have also been implicated in 
the pathogenesis of certain T cell malignant tumors with special 
affini ties for skin [41]. 
Swface Receptors on Langerhans Cells 
The suggestion that LCs are epidermal macrophages has 
received little support. Keratinocytes have proved to be much 
more efficient, as is evident in the readiness with which they 
engulf and process melanin. However, macrophages or histio-
cytes elsewhere in the immune system are similarly inefficient 
as phagocytes. The relationships between LCs and the interdig-
itating reticulum cells (IDCs) of T cell areas of lymph nodes 
and spleen [ 42], the dendritic reticulum cells of germinal centers 
[ 43], and other recently described dendritic cells in spleen [ 44] 
appear to function in antigen presentation rather than process-
ing. 
No evidence has been advanced to support either a Bora T 
lymphocytic natme for LCs. They do not have surface immu-
noglobulin (Sig), nor do they in mice express the e antigen. 
Macrophages, however, express both Fe and C3 receptors, 
which may be detected by rosetting with ovine or bovine 
erythrocytes (the most popular technique) or by other tech-
niques. 
Sting! and colleagues [ 45] reported that a cell suspension of 
human epidermis contained a small (2 to 4%) subpopulation of 
cells t hat formed antibody-coated-erytru·ocyte (EA) (IgG) , but 
not EA (IgM) or erythJ·ocyte (E) , rosettes. Fmthermore, besides 
Fe receptors, t he cells must have possessed C3 receptors since 
they were able to form antibody-and-complement-coated-
erythJ·ocyte (EAC) rosettes. The central cells were A TPase-
positive and were chru·acterized wi th the electron microscope 
as LCs. 
Published reports [46] show that the resetting method may 
be carried out on frozen sections. These techniques have the 
advantage of relating the receptors to cells in particular posi-
tions within tissue. Attempts to demonstrate Fe or C3 receptors 
on LCs in human skin have not been successful [1] , but the 
results described above were confirmed when trypsinized cell 
suspensions were used [1,47]. Trypsin has been reported to 
destroy the C3 receptor on B lymphocytes, but Berman and 
Gigli [ 48] have shown that, as in other macro phages, the 
receptor on LCs is for C-14b23b, and this is not sensitive to 
enzyme digestion. 
Eru·lier, Silberberg-Sinakin and colleagues [ 49] had investi-
gated the interaction of immune complexes and LCs. They 
found that damage to LCs was associated with the presence of 
immune complexes and complement. 
HISTOCOMPATIBILITY, ANTIGENS, AND THE SKIN 
Studies on the histocompatibility antigens of mammals have 
advanced rapidly in recent yeru·s, and much of the terminology 
has changed as newer discoveries have been made. The eru·Jy 
observation that sera from either multipru·ous women or from 
patients receiving multiple transfusions contained leukoagglu-
tinins was followed by the appreciation that leukocytes were 
not the only cells displaying such cell surface antigens. There 
similru·ly followed an appreciation of the importance of the 
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antigens in graft rejection. In man the known genes of the MHC 
are grouped on chromosome 6, and they are of 3 classes. 
First, some genes control the expression of alloantigens ex-
pressed on the surfaces of all nucleated cells. These are the 
HLA-A and HLA-B antigens associated with the concepts of 
transplant rejection. The antigens have a common ,82-micro-
globulin subunit and are capable of eliciting the production of 
alloantibodies upon immunization. They are defined by sero-
logic methods and are, therefore, called SD antigens. 
Second, other genes control the expression of alloantigens of 
more restricted tissue distribution. This series was originally 
defmed by mixed lymphocyte culture (MLC) reactions, i.e., the 
ability to induce blastogenesis when confronted by stimulatory 
lymphoid cells bearing alloantigens. They are the leukocyte-
defined (LD) antigens. These HLA-D series antigens are of 
great interest since the MLC reaction appears to be the in vitro 
equivalent of certain cell-mediated phenomena occurring in 
allograft rejection. The antigens are also capable of inducing 
alloantibody production. 
Third, some genes are coded for the production of a variety 
of serum complement factors, i.e., the HLA-C locus. 
It is now known that the MHC reaction regulates the ability 
of animals to respond to immunologic challenges and it appears 
that much of this potential is restricted to the D locus. 
In animals the MHC reaction has been more extensively 
dissected because of the availability of inbred and congenic 
populations. In mice the H-2 system is on chromosome 17, and 
it has H-2K and H-2D regions comparable to human HLA-A 
and HLA-B regions. Similarly, a region coding for soluble serum 
products is comparable to HLA-C [50]. The Ir (immune-re-
sponse) region controls several important immune phenomena, 
including the ability to respond to certain types of antigen 
[50], the MLC reaction [50-51], the graft-versus-host . (G~H~ 
-reaction [52], allograft rejection (53], T-B cell cooperation 
(54], and T cell-macrop4age cooperation [55]. It has been 
further divided into I-A, 1-B, 1-J, I-E, and I-C subregions. The 
region codes for a set of serologically detectable cell surface 
alloantigens, the Ia antigens. These have a and ,8 polypeptide 
subunits of approximately 33,000 and 28,000 daltons, and they 
lack a common ,Bz-microglobulin subunit. 
Growing evidence supports an analogy between the murine 
Ia antigen and alloantigens expressed on primate B lympho-
cytes, i.e., HLA-DR (HLA-D-region-related) antigens. Indeed, 
there is a close relationship between these and the HLA-D 
antigens associated with stimulation in the MLC reaction (56]. 
One must exercise caution, however. in assuming correspond-
ence of D and DR loci since unusual associations of D and DR 
have been reported [56], and absolute identity cannot be as-
sured. Similarly, although the evidence is good, it is still not 
certain whether Ia antigens are determinants of the Ir genes or 
are merely closely related. In mice the distribution of Ia antigens 
is well known, i.e. , 1-A, 1-E, and 1-C region products are present 
on B cells, some macrophages, sperm, and fetal liver, but not 
on T cells [57]. Certain subsets of T cells, such as suppressor 
cells, appear to express products of the I-J subregion. 
The evidence supporting an analogy between murine Ia an-
tigens and B cell alloantigens rests on their control by homol-
ogous regions of the MHC, their similar tissue distributions, 
their biochemical and molecular characteristics, and similar 
functional properties [58]. 
I a Antigens and Skin 
Interest in the expression of Ia antigens by epidermal cells 
followed the work of Hammerling et al [57]. Using serologic 
methods and especially cytotoxic assays, they showed that 
murine epidermal cells, as well as B lymphocytes, express Ia 
antigens, and Klein [59] also showed that a high percentage of 
epidermal cells express Ia antigen. These estimates have been 
repeated by several groups (60-62]; figures vary from 30 to 90%, 
but in only 1 study were the cells responsible for the activity 
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morphologically assessed [60]. These studies gave no evidence 
that would rule out selective expression on a particular subpop-
ulation of cells in the epidermis. Why Frelinger and associates 
(60] obtained unusually high immunofluorescence is not easily 
explicable. Quantitative absorption studies had suggested that 
epidermal cells expressed 2 to 4 times less Ia antigen than B 
lymphocytes [59,50]. This result was interpreted as evidence 
against the location of Ia antigens on a small supbopulation of 
epidermal cells. However, on the basis of newer findings, the 
LCs appear to express Ia antigens in quantities equal to, if not 
larger than, those of B lymphocytes. It must be noted that Ia 
antigen in the epidermis was concentrated on only 2 to 4% of 
the cells; therefore, the calculations used in the comparison 
with lymphocytes were invalid. 
The availability of appropriate anti-human-HLA-DR anti-
sera was critical to investigations of the distribution of !a-like 
antigens in skin, and several approaches have been taken. 
Alloantisera from multiparous women with reactivity against B 
cell alloantigens [63] are usually of low titer, and they are in 
short supply. The use of hetero- or xenoantisera raised against 
surface glycoproteins of human peripheral blood lymphocytes, 
B celllymphoblastoid cell lines, or leukemia cells has important 
advantages. After appropriate absorption with platelets to re-
move other HLA specificities, such antisera give a broader 
range of staining since they are directed against the common 
determinants of the alloantigens rather than the alloantisera. 
The methods used in producing such antisera have been 
reported several times [64-67]. Basically, the antigens are ex-
tracted from B cells, with either papain digestion or nonionic 
detergent solubilization. The glycoproteins with radioiodine 
label are purified by their affmity for lectins such as lens 
culinaris or concanavalin A (68]. Elution of the bound material 
is achieved with a-methylmannoside.t This fraction is further 
purified by means of sodium dodecyl sulfate-polyacrylamide gel 
electrophoresis, before immunization of rabbits. In view of the 
reported cross-reactivity for various mammalian species (70], it 
is surprising that rabbits respond so vigorously to the antigens. 
The B cell alloantigens, or "!a-like" antigens, have molecular, 
biochemical, and functional properties similar to those of mu-
rine Ia antigen [64-68]. They also show the same tissue distri-
bution, as gauged by cytotoxic and direct immunofluorescence 
assays. Anti-B-cell antisera and laboratory-produced reagents 
are now available commercially [71,72] from Alpha Gamma 
Laboratories, Sierra Madre, California. Besides B lymphocytes 
and certain leukemic cells, macrophages of different species 
stain with such anti-B-cell antisera and anti-Ia alloantisera (73-
75]. 
In 1977, Klareskog and colleagues (76] ·demonstrated that 
human epidermal cells can absorb heteroantibodies against 
HLA-DR antigens. Simultaneous 1977 publications by the 
Swedish group [2] and Rowden, Lewis, and Sullivan [1] dem-
onstrated that only LCs in human skin express HLA-DR anti-
gens. The results were obtained with immunofluorescence stain-
ing (Fig 2). Because of possible interference by Fe receptors on 
LCs, care was taken to use either F(ab')z or Fab' reagents, a 
pertinent fact since the literature contains disputes over the 
separate existence of Fe receptors and Ia antigens [77]. Specific 
immune blocking was also carried out to ensure the specificity 
of the staining. Finally, since neither group used electron mi-
croscopy, skin containing no melanocytes was stained in order 
to rule out the possibility that melanocytes express HLA-DR 
antigens. The stain adhered to the surface of the body and 
dendrites of suprabasal cells. Although quantification from 
frozen sections was difficult, between 2 and 4% of the epidermal 
cells showed positive results. 
t Elleder's [69] observation that epidermal LCs in various pathologic 
conditions stain for cx-D-mannosidase activity may or may not prove to 
be relevant here. We do not know whether such activity is also present 
normally and if it might be involved in the turnover of surface glyco-
proteins, of high mannose content, that bind to lens culinaris. 
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FIG 2. Normal skin; antibody fluorescence wi th an ti-la antiserum 
(indirect). Suprabasal dendritic cells were positively stained (arrows). 
Note the dendritic cell in the dermis (arrowhead) (X 1,000). 
Recent reports [78,79] concerning HLA-DR antigens on ma-
lignant melanocytes are important since neither normal mela-
nocytes nor melanoma cells in tissue sections have been shown 
to express HLA-DR antigens. Why certain melanoma cell lines 
express the equivalent of mw·ine Ia is not clear, but a relation-
ship to the stage of differentiation or to the cell cycle is possible. 
An even more ·recent and puzzling report states that HLA-
DR antigens are detectable on epithelial cells in various parts 
of the gut [80], as well as on the products of mammary gland 
epithelial cells [81]. These 1·eports may reflect situations in 
which cells of the immune system were encouraged to interact 
with epithelium associated with areas of high lgA secretion. 
This phenomenon, however, does not appear to occw· in the 
epidermis. 
The results obtained with immunofluorescence methods need 
to be supported with ultrastructw·al analyses. Experience has 
shown that many problems are associated with immunoelectron 
microscopy (IEM), not the least of which is the preservation of 
both antigenicity and structure; there are also difficulties in 
penetration of reagents. Ia antigen, however, appears to retain 
antigenicity after aldehyde fixation [82]; my colleagues and I 
were able to fix skin in 1.25% buffered paraformaldehyde. By 
preparing 25-llm slices from fixed skin strips with a Sorvall 
tissue chopper and incubating them for lengthy periods, we 
achieved adequate penetration of reagents. When this method 
of tissue processing was used, the LCs, melanocytes, and lym-
phocytes in the epidermis shrank away from surrounding ker-
atinocytes to give the appearance of the so-called clear cells in 
paraffin embedding. Penetration of ferritin -labeled antibodies 
was good, and even the dermis appeared permeable (Fig 3 and 
Fig 4). Therefore, we did not have to use alternative methods 
of IEM to answer our specific question. The results showed 
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FIG 3. Immunoelectron microscopic staining of a Langerhans cell; 
ferrit in-Labeled anti-Ia lgG localization on the cell sw-face (arrows ). 
Note the Birbeck granules (circles) (X 38,500). Inset: higher magnifi-
cation of sw-face labeling (X 55,000). 
that only LCs (indicated by Birbeck granules), not keratino-
cytes or melanocytes, were stained. Histiocytes in the dermis 
and indeterminate cells in the epidermis were also stained 
[ 47]. 
The nature of indeterminate cells has also been debated; 
since some investigators have concluded that they are related 
to melanocytes; others consider them precursors of LCs. We 
noted that between 80 and 85% of such cells in human epidermis 
were stainable with anti-B-cell xenoantisera (83], and inter-
preted this as evidence of .a relationship to LCs. The residual 
indeterminate cells showing no staining may have been related 
to melanocytes or may have been lymphocytes. It is uncertain 
that indeterminate cells exist. By definition cells have to be 
serially sectioned to conclusively show the absence of either 
Bu·beck granules or melanosomes, but the technical problems 
are considerable and experiments are not likely to be canied 
out on the scale necessary to provide unequivocal data about 
the numbers of such cells in the epidermis. Similarly, lympho-
cytes should be identifiable by their characteristic morpholog-
ical featul'es; some consider cells pl'esent in the epidermis of 
patients with mycosis fungoides to be lymphoblasts [84] and 
others have called them indeterminate cells [85]. 
The initial observations described above were confiTmed by 
Sting! and colleagues, who used rosetting methods to obtain 
LCs, stained indirectly by immunofluorescence methods with 
alloantisera from Amish community multiparous women [86). 
This same group also investigated the distribution of Ia antigens 
or their equivalents in guinea pigs [87]. Using strains of guinea 
pigs compatible at most regions of the major histocompatibility 
complex, but disparate at equivalents of theIr region, the group 
obtained alloantisera and thus again showed that epidermal 
cell suspensions contain cells that are Fc-rosettable and that 
can be stained for Ia antigens. The cells were identified as LCs 
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by both an ATPase technique and electron microscopy. As in 
the human studies, between 2 and 6% of the epidermal cells 
were !a-positive; this percentage corresponded to the known 
frequency for LCs. 
These results were clearly at variance with results obtained 
in the mouse. We reinvestigated the murine system with both 
immunofluorescence and IEM methods, with specific alloanti-
sera. As in man and guinea pigs, only a small percentage of 
epidermal cells were stained with antisera directed against I-A 
and I-E/C subregion products [88] (Table). Immunoelectron 
microscopy demonstrated the cells to be LCs. These results 
have now been confrrmed by Tamaki and associates [89] and 
by Frelinger and associates [90]. The latter group reassessed 
their earlier statements suggesting a rather uniform epidermal 
cell expression of Ia antigens, and employed a novel approach 
to answer the question raised by the studies in man and guinea 
pigs. On the assumption that LCs were bone-marrow-derived 
(see Origins of Langer hans Cells subsection), they thought that 
in radiation-induced bone marrow chimeras, cells appearing in 
FIG 4. lmmunoelectron microscopic staining of a dermal histiocyte; 
ferritin-labeled anti-Ia IgG localization on the cell surface (arrows) 
(X 33,000). Inset: higher magnification of surface labeling (X 49,500). 
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the epidermis and detected by specific antisera against Ia 
antigens would be of mesodermal origin and, therefore, LCs 
rather than keratinocytes. Within 3 to 4 months of chimera 
production, this hypothesis proved to be correct [90]. It is still 
not possible to explain the high percentages obtained in the 
cytotoxic assays of earlier studies in mice. Langerhans cells are 
the targets of cytolytic antibody reactions, but when damaged 
they cause associated damage to surrounding keratinocytes in 
cell suspensions. Release of lysosomal enzymes from LCs might 
fulfill this role. 
It now seems clear that in the mammalian species so far 
examined, only LCs or their precursors in the epidermis express 
Ia antigens or their equivalents. Whether similar results will b e 
obtained in other species and whether equivalent cells involved 
with contact allergic phenomena may be found in avian species 
remain to be determined. 
FUNCTIONS OF LANGERHANS CELLS: 
SPECULATIONS AND PROOF? 
Assigning the expression of HLA-DR on Ia antigens to a 
single population of cells in the epidermis is not a trivial or 
academic exercise since this achievement goes a long way 
toward explaining many phenomena involving skin. Skin has 
long been known as a prime target for immune phenomena, and 
the suggestion has been made that it is a primary lymphoid 
organ [91]. 
An average adult man has a surface area of about 2m2. With 
around 500 LCs/mm2, he has approximately 2 X 109 cells. This 
figure does not include those in the outer root sheaths of hair 
follicles or in the oral mucosa and esophagus, and is, therefore, 
conservative. Compared to other cells of the immune system 
they are r elatively scarce, but their location is critical to inter~ 
ception of chemical substances impinging on the body surface 
from the environment. The regular distribution of cells, with 
gaps as little as 30·/lm, provides an excellent surveillance system. 
As discussed in the context of contact allergy, LCs were 
suspected of not only transporting allergen to lymph nodes, but 
also, once there, displaying them in a relevant manner. The 
result of such a process would be the production of clones ofT 
cells specifically sensitized to the allergen. As has been dem-
onstrated for macro phages, there are genetic restrictions for the 
presentation of T -cell-dependent antigens to lymphocytes 
[92]. Antigen presentation on macrophages syngeneic to the 
responding T cells is essential for the response. 
Stingl and colleagues have demonstrated that LCs can re-
place macrophages in this antigen presentation [93,94]. (It is 
essential that both cells be syngeneic at Ir loci.) Furthermore, 
using the same method of isolating LC-enriched fractions of 
epidermal cell suspensions, they have shown that LCs are 
efficient stimulatory cells in an MLC. Thus, as is true for 
macrophages from other sources, there is a genetic restriction 
in that disparities between stimulatory and responding cells are 
necessary at the lr loci. Evidence is accumulating that macro-
phages may be the major stimulatory cells in MLCs [95,96). 
Bearing in mind earlier suggestions concerning the amounts of 
HLA-DR antigens expressed on LCs, one can see that the cells 
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may be very active in such cultures. Since the MLC is perhaps 
the in vitro equivalent of generation of cytotoxic or killer 
lymphocytes in allograft rejection, this finding has significance 
in any analysis of skin transplantation phenomena. 
The normal physiological role for Ia antigen expression of 
LCs is not known. CleaTly, the system was not designed to elicit 
rejection of transplants since this does not occm frequently in 
nature. Perhaps they play a role in the recognition of viral and 
microbial intrusions into the body. Viruses have been noted 
within LCs [97], but it is not known whether viral antigens are 
displayed in association with Ia antigens on the surface. A 
model has been proposed to account for the genetic restrictions 
observed in T-cell-mediated lysis of target cells infected with 
choriomeningitis virus in the mouse [98]. It remains to be 
determined whether complexing of viral antigens with swface 
Ir-region products plays an important role in host defenses in 
the skin. 
I a Antigens and Allograft Rejection 
In kidney transplantation the matching forB cell alloantigens 
can have an important influence on the outcome [99]. Although 
matching for HLA-DR antigens apperu·s to predict survival 
better than matching for HLA-A orB antigens, the results ru·e 
still not as good as when MLC negativity is used. 
Earlier studies suggested that allograft rejection involved 
biphasic sensitization and reaction stages, i.e., that cells bearing 
LD antigens (Ia and HLA-DR) acted only as initial stimulators 
for the eventual production of killer T cells capable of reacting 
with SD (HLA-A and B) antigens in allografts [100]. Feighery 
and Stastny [101], however, showed that the stimulatory cells 
may also act as targets for the cell-mediated lymphocytic phe-
nomena they set in motion. In mice H-2.1 antigens may act as 
targets as efficiently as the H-2D or H-2K antigens. Langerhans 
cells, and therefore possibly the HLA-DR antigen they beru·, 
are probably the targets for cytotoxic lymphocytes in contact 
allergic phenomena. It is not a coincidence that the initial focus 
of damage in the challenge reaction is associated with lympho-
cytic infiltration into the epidermis [26,35]. Epidermal necrosis 
is commonly associated with contact reaction, but delayed 
hypersensitivity reactions associated with intradermal injec-
tions are mainly directed against dermal cells. A similru· target 
role for LCs in cutaneous T cell lymphomas has been suggested 
[41]. Tjernlund [102] found ~ncreases in numbers o! HLA-J?R-
positive cells in the epidermis of later~stage mycosis fungo~des 
patients (102]; these increases may be mterpreted as replemsh-
ment of damaged LCs [85]. 
If LCs in skin and the HLA-DR antigen they express are 
responsible for triggering allograft rejection, the exquisite sen-
sitivity of the tissue to transplantation would be explainable, as 
would the skin manifestations associated with the GVH reaction 
[103]. . 
The epidermis contains passenger lymphocytes [104] and the 
lymphocytes in the allografts are very important in transplan-
tation [25]. The population of immunologically competent cells 
within the epidermis, however, may prove to be as important 
as, if not more important than, lymphocytes, and consideration 
should be given to "resident cells" as well as to "passenger 
cells." Langerhans cells do not apperu· to contribute to passenger 
cell phenomena in kidneys, thyroids, and ovru·ies, but perhaps 
similar resident histiocytes there also contribute to the phenom-
ena. 
Thus, the reasons for the cwTent interest in the origin and 
kinetics of LC turnover center around their possible manipu-
lation for transplantation. 
Mixed Skin-Leulwcyte Reactions 
Epidermal cells in suspension ru·e capable of replacing lym-
phocytes as stimulators in MLCs in man [105,106], the mouse 
[107], and the rat (108]. The system has advantages in that 
there is no "back stimulation" from lymphokines produced by 
epidermal cells. This replacement is only theoretical, however, 
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since we do not know what secretory products are elaborated 
by LCs. Similarly, although the epidermis should not need to 
be irradiated for prevention of proliferation, as in 1-way MLCs, 
little is known about the proliferative capacity of LCs. 
Serious efforts have been made to rule out the possible 
influence of passenger lymphocytes in the various mixed skin-
leukocyte (MSL) reaction systems. These include the produc-
tion of radiation chin1era·s [109,110] and the use of thymidine 
pulse techniques [111]. However, although the existence of 
epidermal-cell-specific or Sk (skin-specific) antigens has been 
proposed as being responsible for the MSL reactions [112], 
experiments have not conclusively ruled out possible contami-
nation with host immune cells. The facts that LCs are radiore-
sistant [26] and that they may be slowly replaced in normal 
epidermis suggest they may smvive in the skin of radiation 
chimeras. New investigations with appropriate congenic animal 
models and irradiation systems ensuring true chimerism will be 
necessary before the existence of Sk antigens can be substan-
tiated. 
I believe that the stimulatory cells mentioned above are LCs. 
If they really are, the outlook for clinical transplantation of skin 
would be somewhat improved since attempts to evade rejection 
phenomena might be directed at the manipulation of LC pop-
ulations rather than at matching for Sk antigens. 
Corneal Langerhans Cells 
Malinowsky et al [113] have shown that corneal epithelial 
cells ru·e capable of eliciting an MLC reaction with appropriate 
responder lymphocytes. This observation is of some impor-
tance, as will be shown in the discussion below about LCs in 
the cornea. 
A problem exists in determining the role of LCs in skin graft 
rejection. It may be possible to obtain epidermal samples devoid 
of LCs, but the underlying dermis also contains many cells, 
either related or unrelated to LCs, that may be equally capable 
of stimulating allograft rejection. Recent studies by Streilein 
and colleagues hold a possible solution to these problems. 
Corneal grafting has met with g1·eat success, mainly because of 
the natme of the recipient site. Furthermore, the cornea is 
immunogenic, and when placed on a prepared skin bed it is 
rejected (114]. Corneal epithelium, however, contains very few 
LCs, except at the limbus [115] (Fig 5). With mice of appropriate 
H-2 constitutions, i.e., H-2-K- and H-2D-compatible but Ir-
region-dispru·ate, it is possible to show that corneal grafts to 
skin sites are not rejected.:j: The implication is that corneas do 
not contain !a-expressing cells, and Klareskog and colleagues 
[116] have confirmed that few HLA-DR-positive cells are pres-
ent in the epithelium; the underlying stroma also apparently 
has few passenger cells. Clearly, the cornea model is relevant to 
the question of whether the presence of !a-bearing cells, in an 
otherwise compatible epithelium, influences graft rejection. We 
have recently induced migration of LCs into central corneal 
epithelium by vitamin-A-deficient diets, application of irritants, 
and contact sensitization methods (Fig 6). We are in the process 
of assessing whether such LC-seeded corneas affect the rate of 
allograft rejection. 
The cornea model has additional relevance to the kinetics of 
LC turnover in epithelium previously devoid of the cell. The 
fact that LCs appear in corneas within 5 days of an appropriate 
challenge suggests that in certain circumstances they may be 
recruited rather swiftly either locally or from bone marrow. 
Rapid shifts in LC numbers have _been noted in challenge 
reactions to contact allergens, and local precursor cells have 
been implicated [117]. 
ENHANCEMENT AND TOLERANCE 
Results showing that passive administration of anti-Ia anti-
sera can provide some degJ·ee of protection for subsequent skin 
:J. Streilein JW , Toews G, Bergstresser P, personal communication. 
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FIG 5. Limbus region of mouse cornea; separated epithelial sheet 
stained for ATPase. Note the Langerhans cells (arrows) . There was no 
positive staining in the central region (*)(X 175). 
allografts (59,118,119] have been interpreted as an effect on the 
induction of the initial helper T cells (Ly 1 +2- T) , necessary for 
the generation of cytotoxic killer T cells (Ly 1- 2+3+). The delay 
in generation of cytotoxic T cells ensures an absence of anti-H-
2D and anti-H-2K activity. Anti-H-2K antiserum produces 
some enhancement, but anti-I-region antisera are many times 
more efficient. Prolonged treatment, however, does not ensure 
permanent survival. It is possible that the anti-Ia antiserum 
ablates the LC population in the graft and thereby prevents 
migration and sensitization in lymph nodes, or blocks peripheral 
sensitization. 
Maximum enhancement occurs if the grafting is carried out 
soon after administration of the antiserum, which appears to 
react with the graft itself. The kind of cell interacting with the 
anti-Ia antibodies in the graft is unknown, but B lymphocytes 
and histiocytes in the dermis and LCs in the epidermis are 
possible candidates. Such cells may be responsible for the 
sensitization phase alone or may also. act as targets. 
The fact that epidermal cells may be used to efficiently 
induce tolerance in neonatal mice is evidence for the existence 
within such suspensions of cells of mesenchymal origin [120]. 
The fact that more epidermal cells than spleen cells are required 
to produce the effect [121] is explicable; there is approximately 
a 20:1 keratinocyte:LC ratio diluting the tolerizing cells. 
A final point is that induction of tolerance to SD antigens 
has proved to be somewhat easier when LD antigenic stimuli 
are not used in the induction procedures [122]. 
Organ Culture 
Several studies on methods of removing passenger cells from 
grafts have indicated that long-term organ culture can result in 
permanent survival of thyroid and ovarian allografts [123,124] 
and xenografts [125]. It is doubtful that such a system works 
for skin since attempts to reproduce the results of Summerlin 
et al [126] by Ninneman and Good [127] have failed. Janssen 
de Limpens et al [128], however, have succeeded in prolonging 
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FIG 6. Central corneal epithelial region 6 days after dinitrochloro-
benzene challenge. The Langerhans cells stained positively for A TPase 
(arrows) (X 175). 
allograft survival after organ culture. Although their study does 
not rule out the possibility of graft invasion by recipient epi-
dermis rather than true graft survival, one could construct an 
hypothesis to explain the results. The skin in organ culture 
undergoes characteristic histological changes [129,130], and 
passenger lymphocytes in the dermis, as well as LCs in the 
epidermis, could become reduced in number; more detailed 
investigation of the LC population in organ culture is required 
to prove this hypothesis. 
An observation relevant to manipulations affecting allografts 
was made by investigators studying the effects of placing mice 
in simulated conditions of an 18,000-ft altitude for 14 days 
[131]. The mice were more receptive to allografts and their skin 
was more tolerated by normal animals, but this effect could 
have been mediated through LC depletion! 
Passenger versus Resident Cells 
Several puzzling observations have been made on the rejec-
tion of skin isografts. SteinmulleT [132] showed that skin iso-
grafts from mice made tolerant to allogeneic tissue by neonatal 
injections are capable of immunizing isogeneic recipients to 
further skin grafts. Isografts do not normally stimulate trans-
plantation immunity. It is assumed that immunizing isografts 
are the vehicles for transplantation antigens and yet evade 
rejection. The presence in skin of transient or permanent pas-
senger lymphoid cells could account for these observations. But 
the kinetics of the replacement of LCs of a given histocompat-
ibility type by others with the genetic background of the toler-
izing bone marrow or spleen is vital to the unraveling of this 
problem. 
Billingham over the years has championed the importance of 
passenger lymphocytes in graft rejection [25,133,134]. Passenger 
cells have been implicated either directly or indirectly in several 
cases of anomalous immunogenicity of skin grafts. Present 
evidence suggests that host leukocytes are the principal source 
of antigen in all local and systemic GVH disease phenomena, 
but the efficacy of such procedures on LC populations in the 
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FIG 7. Possible precu1·sors of the Langerhans ceil (Lc ), including 
bone marrow, interdigitating reticulum ceil, and dermal histiocyte. 
many experiments designed to manipulate or purge skin of 
passenger lymphocytes needs to be reassessed. Epidermal grafts 
free of passenger lymphocytes apparently are rejected with no 
real prolongation (135]. However, there is no information from 
these experiments related to the presence or absence of LCs. 
ORIGIN OF LANGERHANS CELLS 
In the course of this review there have been hints that LCs 
originate from bone marrow. Katz, Tamaki, and Sachs' work 
on radiation chimeras (136] and the studies by Frelinger et al 
[90] clearly show that bone manow grafting with appropriate 
strain differences in the Ir gene region permits tracing of the 
anival of !a-positive cells in the epidermis. Several months 
seem to be necessary before the donor strain LCs completely 
replace those in the recipient skin. Since bone marrow grafting 
is now a relatively common procedme in the treatment of 
people with various hematologic disorders, there must be many 
examples of the repopulation of LCs in human skin. A detailed 
study on this group of patients should prove illuminating since 
GVH disease is a common complication of such procedures. 
Although LCs may arise from bone marrow monoblasts, 
nothing is known about the relative pool sizes of other possible 
precmsor cells (Fig 7) . Evidence is accumulating of the existence 
of cells within the lymph nodes and spleen with structural 
[137,138], antigenic (139], and functional likenesses to LCs. The 
IDCs of the lymph nodes may be part of a system of cells 
involved primarily with antigen presentation to lymphocytes. 
The !a-positive, dendritic cell population in the spleen described 
by Steinman and Witmer (44] may similarly be related, even 
though it lacks Fe and C3 receptors (140]. It is not known 
whether both LCs and dendritic cell populations in lymph 
nodes and spleen are replaced independently from bone mar-
row, or whether there is intrapool migration. 
Perhaps indeterminate cells [141,142] represent immigrant 
LCs, but it is not known if these are from the dermis or are in 
transit from other sources. The morphological types ofLC have 
been under scrutiny in recent years, and Breathnach [143) has 
stated that a relationship may exist between a population of 
relatively undifferentiated cells in t he dermis and LCs. The 
cells with few BiJ·beck granules present in the basal layers of 
normal and traumatized skin [144,145] may represent newly 
anived precursor cells that have not yet developed the distinc-
tive granules. 
A final word of caution must be added concerning the tum-
over of LCs. Some studies have shown that with thymidine 
labeling LCs are capable of mitosis in the epidermis (146,147]. 
These do not, however, rule out migration of cells. MacKenzie 
(148] has shown that sister cells with the radiolabel were seen 
at significantly long periods of time after pulse labeling. Per-
haps, in normal circumstances, epidermal LCs maintain them-
selves by mitosis, a nd are augmented by precursor cell immi-
gration on antigenic stimulation . 
BIRBECK GRANULES 
An understanding of the relationship of Bil·beck granules to 
the control of differentiation and keratinization has been se-
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verely hampered by the failw·e to obtain organelles for bio-
chemical characterization. 
It is not clear whether the granules are endocytotic (149, 
150], or m;ginate in the Golgi complex [8] and are, therefore, 
secretory in nature. They do not appear to be involved in the 
phagocytosis of antigens, and studies on cell surface formation 
have largely been based on pathologic specimens. Since mac-
rophages are known to secrete a variety ·of substances with both 
ilnmunologic and nonimmunologic functions, it is not unreason-
able to think the LCs have some similar capacities. 
In an attempt to investigate the antigenic properties of Bil·-
beck granules, we have tried to determine, with IEM, whether 
they bear Ia antigens. Because of the problem of antibody 
penetration, we used various fixative regimens in addition to 
dilute paraformaldehyde [151] and pretreated cells with saponin 
to create pathways for penetration [152]. Despite the obvious 
efficiency of penetration of the microperoxidase-labeled Fab' 
fragments, no technique has permitted us to state that Bil·beck 
granules bear Ia antigens. At this ti111e, we do not think that 
Birbeck granules are involved in the movement or display of Ia 
antigens on the surfaces of LCs. They are still an enigma. 
The technical assistance of Miss E. Rusnock, Mr. N. More, and Mr. 
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